These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 9007104)
1. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104 [TBL] [Abstract][Full Text] [Related]
2. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734 [TBL] [Abstract][Full Text] [Related]
3. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex. Ess KC; Kamp CA; Tu BP; Gutmann DH Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742 [TBL] [Abstract][Full Text] [Related]
4. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Geist RT; Reddy AJ; Zhang J; Gutmann DH Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918 [TBL] [Abstract][Full Text] [Related]
5. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression. Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204 [TBL] [Abstract][Full Text] [Related]
6. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687 [TBL] [Abstract][Full Text] [Related]
7. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320 [TBL] [Abstract][Full Text] [Related]
8. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Plank TL; Logginidou H; Klein-Szanto A; Henske EP Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994 [TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993 [TBL] [Abstract][Full Text] [Related]
10. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308 [TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694 [TBL] [Abstract][Full Text] [Related]
12. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103 [TBL] [Abstract][Full Text] [Related]
13. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Soucek T; Hölzl G; Bernaschek G; Hengstschläger M Oncogene; 1998 Apr; 16(17):2197-204. PubMed ID: 9619828 [TBL] [Abstract][Full Text] [Related]
14. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients. Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698 [TBL] [Abstract][Full Text] [Related]
15. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. Takahashi DK; Dinday MT; Barbaro NM; Baraban SC Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510 [TBL] [Abstract][Full Text] [Related]
16. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis. Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Mizuguchi M; Ikeda K; Takashima S Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
19. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S Acta Neuropathol; 1997 Dec; 94(6):525-31. PubMed ID: 9444353 [TBL] [Abstract][Full Text] [Related]
20. Hamartin and tuberin expression in human tissues. Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]